LimaCorporate Enters Into An Agreement With Dedienne Sante’ For Distribution Of Dual Mobility Cups

San Daniele del Friuli, Udine, Italy – 15h of October 2019 – LimaCorporate announces the completion of a Distribution Agreement with Dedienne Santé S.a.s. for the Dual Mobility SYMBOL acetabular cup portfolio in almost all countries in the European Economic Area (EEA) and Switzerland. According to the agreement, the products will be fully integrated into the LimaCorporate Large Joints Business Unit.

This agreement follows the orthopedic market requirements, providing energy, dynamism and innovation, satisfying a wider range of surgeons’ requests.

About LimaCorporate

Advertisement

LimaCorporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, LimaCorporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. LimaCorporate’s product range includes large joint revision and primary implants and complete extremities solutions including fixation. For additional information on the Company, please visit: limacorporate.com.

Limacorporate S.p.A.

Via Nazionale, 52

33038 Villanova di San Daniele

Udine – Italy

T: +39 0432 945511

E: info@limacorporate.com

About Dedienne Santè

Dedienne Santé is part of the Menix Group, a French holding company that brings together the leading brands in orthopedics, dental implants and craniomaxillofacial surgery. The Menix Group is led by Patrick Rondot, and has its own roots in the expansion of the Dedienne plant, which has more than 30 years of specialization in the manufacturing of orthopedic implants. For additional information on the Company, please visit: dediennesante.com

Dedienne Santé

315 Rue Charles Tellier

30034 Nîmes Cedex 1,

France

T: +33 (0)4 66 28 06 85

E: contact@dedienne-sante.com

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement